Patent 7741330 was granted and assigned to Pharmacyclics on June, 2010 by the United States Patent and Trademark Office.
Described herein are kinase inhibitor compounds, methods for synthesizing such inhibitors, and methods for using such inhibitors in the treatment of diseases. Further described herein are methods, assays and systems for determining an appropriate inhibitor of a protein, including a kinase.